Is stem cell therapy for Autism Spectrum Disorder FDA-approved?
No regenerative medicine therapy is FDA-approved to treat autism. A clinic registration, laboratory certificate, trial listing or claim that a product is autologous does not change product-level approval. Verify the exact product and use with the relevant regulator.
How stem cells are studied for Autism Spectrum Disorder
Autism is a lifelong neurodevelopmental condition with diverse communication, sensory, behavioural and support needs. Cell-based proposals usually invoke immune modulation or neural plasticity, but those mechanisms remain hypotheses and do not establish improvement in core autistic features. Placental, amniotic, cord-derived, stromal and exosome products are not interchangeable, and evidence for one preparation cannot validate another.
Am I a candidate? → · Autism Spectrum Disorder: full overview → · Autism Spectrum Disorder cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Autism Spectrum Disorder: cell-therapy evidence and registered trials
- How much does stem cell therapy for Autism Spectrum Disorder cost? (2026)
- Autism Spectrum Disorder stem cell therapy — your questions answered (2026)
- Autism Spectrum Disorder: cell-therapy evidence by therapy class
- MSC vs exosomes for Autism Spectrum Disorder: what the registries show